On Invalid Date, Theravance Biopharma (NASDAQ: TBPH) reported Q4 2023 earnings per share (EPS) of -$0.19, up 200% year over year. Total Theravance Biopharma earnings for the quarter were -$8.51 million. In the same quarter last year, Theravance Biopharma's earnings per share (EPS) was $0.19.
As of Q1 2024, Theravance Biopharma's earnings has grown year over year. Theravance Biopharma's earnings in the past year totalled -$55.19 million.
What is TBPH's earnings date?
Theravance Biopharma's earnings date is Invalid Date. Add TBPH to your watchlist to be reminded of TBPH's next earnings announcement.
What was TBPH's revenue last quarter?
On Invalid Date, Theravance Biopharma (NASDAQ: TBPH) reported Q4 2023 revenue of $17.57 million up 19.91% year over year. In the same quarter last year, Theravance Biopharma's revenue was $14.65 million.
What was TBPH's revenue growth in the past year?
As of Q1 2024, Theravance Biopharma's revenue has grown 11.84% year over year. This is 157.46 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Theravance Biopharma's revenue in the past year totalled $57.42 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.